Northern Trust
AEON icon

Northern Trust’s AEON Biopharma AEON Stock Holding History

Northern Trust’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-656
Closed -$25.5K – 4418
2024
Q4 		$25.5K Sell
656
-65
-9% -$3.79K ﹤0.01% 4356
2024
Q3 		$54.5K Hold
721
– – ﹤0.01% 4187
2024
Q2 		$54.5K Buy
721
+43
+6% +$10.2K ﹤0.01% 4194
2024
Q1 		$566K Sell
678
-14
-2% -$10.1K ﹤0.01% 3525
2023
Q4 		$359K Buy
692
+241
+53% +$96.8K ﹤0.01% 3663
2023
Q3 		$182K Buy
+451
New +$207K ﹤0.01% 3851

Other funds holding AEON

DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
DCM
Dupont Capital Management Wilmington, Delaware $2.18M AUM 50.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Northern Trust's AEON Position: Q1 2025 in Review

Northern Trust sold out of AEON Biopharma (AEON) in Q1 2025, closing a stake of 656 shares — an estimated $25.5K sold.

Northern Trust first reported a position in AEON in Q3 2023 and held it in 6 quarters. The position peaked at $566K in Q1 2024. 16 funds tracked by Wall St. Rank hold AEON as of Q1 2025.

  • Northern Trust reported no remaining AEON Biopharma position as of Q1 2025 after selling out during the quarter.
  • Northern Trust sold 656 AEON Biopharma shares in Q1 2025, an estimated $25.5K.
  • Northern Trust first reported a position in AEON Biopharma in Q3 2023 and held it in 6 quarters.
  • Northern Trust's AEON Biopharma position peaked at $566K in Q1 2024.
  • 16 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2025.

Based on Northern Trust's 13F filing for Q1 2025, filed 13 May 2025.